Navigation Links
Dr. Daniel Spyker, Former FDA acting Deputy Division Director of Cardiovascular, Respiratory, and Neurological Devices, Joins NDA Partners
Date:2/22/2017

NDA Partners Chairman Carl Peck, MD, announced today that Dr. Daniel Spyker, PhD, MD former Acting Deputy Director in the FDA CDRH Division of Cardiovascular, Respiratory, and Neurological Devices and Medical Officer in CDER’s Pilot Drug Evaluation Staff has joined the company as an Expert Consultant.

In Dr. Spyker’s accomplished career, he held positions as Senior Director of Drug Safety and Pharmacovigilance at Alexza Pharmaceuticals; Director, Pharmacokinetics and Pharmacodynamic Sciences, Genentech, where he established the clinical pharmacology unit; and Senior Medical Director, Clinical Risk Assessment and Coordination Department at Purdue Pharma.

Dr. Spyker was a member of the Internal Medicine faculty in the Division of Clinical Pharmacology at the University of Virginia for 10 years, where he fostered and nurtured the Blue Ridge Poison Center. He was also founder and CEO of a software company specializing in poison center data collection and Bayesian pharmacokinetic applications.

“Dr. Daniel Spkyer’s knowledge and expertise of cardiovascular, respiratory, and neurological devices at FDA and in the Industry, in addition to his expertise in quantitative clinical pharmacology and toxicology, make him an excellent addition to NDA Partners. He will bring great value to our medical device clients and we are very pleased to welcome him,” said Dr. Feigal, who heads NDA Partners’ Medical Device Practice.

Dr. Spyker earned his PhD from the University of Minnesota in Electrical Engineering and Mathematics, his MD from the University of Virginia, and MS from Purdue University. He is board certified in Internal Medicine, a diplomate of the American Board of Medical Toxicology, and diplomate of the American Board of Clinical Pharmacology.

About NDA Partners
NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle(at)ndapartners(dot)com

Read the full story at http://www.prweb.com/releases/2017/02/prweb14083870.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Industry Leaders DuPont & Archer Daniels Midland Win Platts Global Energy Breakthrough Solution of the Year Award
2. Danielle Vitiello, MD of Fertility Centers of New England, Named New Medical Director
3. Danielle Vitiello, MD of Fertility Centers of New England, Named Top Doc in Infertility Diagnosis and Treatment by NH Magazine
4. Global Regulatory Affairs Expert Daniela Drago, PhD Joins NDA Partners
5. Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board
6. XBiotech Adds Daniel Vasella to its Board of Directors
7. Tarsa Therapeutics Secures $10 Million And Adds Industry Veteran Daniel Soland As A Director
8. Dr. Daniel Von Hoff Joins Lixte Biotechnologys Scientific Advisory Board
9. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
10. Repetitive Head Injuries May Not Cause Movement Problems for Former NFL Players
11. Dr. Deborah Wenkert Pediatrics Expert and Former Amgen Clinical Research Medical Director, Joins NDA Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2018)... ... 2018 , ... The American Medical Informatics Association (AMIA) is proud to announce ... at the AMIA 2018 Annual Symposium , taking place Nov. 3 – 7, ... garnered more than 700 submissions. The AMIA Signature Awards program provides an opportunity for ...
(Date:10/11/2018)... , ... October 11, 2018 , ... ... label printing and software solutions, in collaboration with HP, the global leader in ... Avery UltraDuty GHS Chemical Labels on all HP PageWide Printers. , The award-winning ...
(Date:10/5/2018)... ... October 04, 2018 , ... Earthres Group, Inc., a ... the company’s brand identity and better reflects its current breadth of markets and ... engineering expertise and related support services to clients in seven market sectors, and ...
(Date:10/2/2018)... ... October 02, 2018 , ... Contamination is ... reliability and reproducibility of experimental data. Each lab must consider whether ethanol and ... which is sponsored by Eppendorf , attendees will learn how to recognize ...
Breaking Biology Technology:
(Date:10/13/2018)... , ... October 12, 2018 , ... ... it will host a booth at premier packaging event PACK EXPO International in ... Packaging Machinery Manufacturers Institute (PMMI), of which HOLLOWAY AMERICA is a member. , ...
(Date:10/11/2018)... ... ... ODSC Europe 2018 - one of Open Data Science Conference , ... September 19-22. , As Europe’s largest applied data science conference, ODSC Europe featured ... Attendees were given key insights and hands-on training in deep learning, machine ...
(Date:10/5/2018)... Ill. (PRWEB) , ... October ... ... Edwardsville, in partnership with the University of Illinois Extension and Monroe County ... Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) Non-Land ...
Breaking Biology News(10 mins):